<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bae HR</submitter><funding>National Research Foundation of Korea</funding><pagination>297</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12411337</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>74(9)</volume><pubmed_abstract>Although checkpoint immunotherapy has primarily focused on CD8⁺ T cells, emerging evidence highlights an important role for cytotoxic CD4⁺ T cells in mediating therapeutic responses. However, research on the functional properties of cytotoxic CD4⁺ T cells in the context of immunotherapy is still at an early stage and remains insufficiently defined. Utilizing single-cell RNA-sequencing datasets obtained from metastatic melanoma patients treated with checkpoint inhibitors targeting PD-1 and/or CTLA-4, we performed transcriptomic profiling of conventional CD4⁺ T cells, excluding proliferative and regulatory (FOXP3⁺) subsets, and compared responders and non-responders as distinct groups. Importantly, our analysis identified distinct clusters that discriminate between responders and non-respond</pubmed_abstract><journal>Cancer immunology, immunotherapy : CII</journal><pubmed_title>Cytotoxic CD4⁺ T cells exhibit an immunosuppressive shift in checkpoint immunotherapy resistance in melanoma patients.</pubmed_title><pmcid>PMC12411337</pmcid><funding_grant_id>RS-2024-00342528</funding_grant_id><funding_grant_id>RS-2023-00213596</funding_grant_id><pubmed_authors>Kim S</pubmed_authors><pubmed_authors>Bae HR</pubmed_authors><pubmed_authors>Son B</pubmed_authors><pubmed_authors>Young HA</pubmed_authors><pubmed_authors>Kwon EY</pubmed_authors><pubmed_authors>Hwang K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cytotoxic CD4⁺ T cells exhibit an immunosuppressive shift in checkpoint immunotherapy resistance in melanoma patients.</name><description>Although checkpoint immunotherapy has primarily focused on CD8⁺ T cells, emerging evidence highlights an important role for cytotoxic CD4⁺ T cells in mediating therapeutic responses. However, research on the functional properties of cytotoxic CD4⁺ T cells in the context of immunotherapy is still at an early stage and remains insufficiently defined. Utilizing single-cell RNA-sequencing datasets obtained from metastatic melanoma patients treated with checkpoint inhibitors targeting PD-1 and/or CTLA-4, we performed transcriptomic profiling of conventional CD4⁺ T cells, excluding proliferative and regulatory (FOXP3⁺) subsets, and compared responders and non-responders as distinct groups. Importantly, our analysis identified distinct clusters that discriminate between responders and non-respond</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-05-29T19:43:38.688Z</modification><creation>2026-04-08T05:50:29.448Z</creation></dates><accession>S-EPMC12411337</accession><cross_references><pubmed>40906211</pubmed><doi>10.1007/s00262-025-04145-6</doi></cross_references></HashMap>